- 1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer
- BlackRock’s UK BRAI Trust Bets on AI-Led Turnaround — Will Investors Buy In?
- 3 Tesla Growth Catalysts You Cannot Ignore in 2025
- 3 Resilient Tech Stocks Thriving Amid the 2025 Market Storm
- S&P 500, Nasdaq Extend Gains—but Approaching Resistances Could Put Rally to Test
- Alphabet Q1 Earnings Fallout: Don't Underestimate Google Parent's Strong Momentum
- Nasdaq 100: Elliott Wave Says the Bear Market Was a Setup for New ATHs
- Trump Backs Off Tariffs—These 2 Tech Stocks Could Bounce Next
- Foxtons: Strong Q1 and Share Buyback Position It for Medium-Term Profit Upgrade
- Nasdaq 100: Bulls Need a Clean Breakout Above 19,500 to Reclaim 20,000 Mark
- IBM Rallies on Earnings, Then Crashes as DOGE Cuts Bite
- Alphabet Q1 Earnings Preview: Bulls Eye Rebound on Fundamentals Boost, AI Updates
- UnitedHealth: Q1 Decline Makes Undervalued Stock a Strong Buy With Dividend Upside
- GoGold Builds Momentum Across Los Ricos Projects With New Drilling Results
- Unilever Bets on Magnum Spin-Off, Margins, and Emerging Markets—Will It Pay Off?
